1. Introduction {#s0005}
===============

With rapid advances in biotechnology, a large number of peptides have been developed as therapeutic agents[@bib1]. For example, topical application of acetyl hexapeptide-3 is used to treat facial wrinkles and may be of value in repairing skin[@bib2; @bib3]. Acetyl hexapeptide-3 is about 4000 times less toxic than botulin toxin[@bib4]. In addition, this drug does not require injection, and can be topically used on the skin. However, the hydrophilic nature of these peptides limits the efficacy of these drugs applied topically, because of poor transdermal penetration[@bib5]. Thus, the major challenges of transdermal peptide delivery are poor permeability, low bioavailability and regulatory issues.

Microneedles have been proposed to be a kind of delivery system which permits entry of small-molecule drugs, therapeutic proteins and vaccines, with minimal skin invasiveness[@bib6; @bib7]. Although there is a growing interest in the microneedle-based drug delivery system and a significant development in its application, the use of microneedles for delivery of hydrophilic peptides with low molecular weight have not been investigated in detail. Previously, we reported that microneedles significantly increase the transdermal delivery of hydrophilic [l]{.smallcaps}-carnitine in comparison to passive diffusion, and enhance substantially the bioavailability of this peptide compared to oral administration[@bib8]. Microneedles have also been found to increase the skin permeation of calcein, insulin, vaccine and liposome[@bib9; @bib10]. So far, the solid microneedles have been proved to be an efficient and affordable approach for the delivery of transdermal drug.

Enhancement of transdermal drug delivery is probably related to convective solvent flow. For instance, Manabe et al.[@bib11] evaluated the effect of convective flow on iontophoretic skin transport based upon the hydrodynamic pore theory. Morimoto et al.[@bib12] investigated the relationship between hydrophilic solute and water transport during ultrasound application, and found that 41 kHz ultrasound can increase the permeation of hydrophilic solutes by inducing convective solvent flow *via* new routes[@bib13]. Similarly, microneedles create transient aqueous microchannels which serve as multiple pathways for hydrophilic drug transfer[@bib14]. Therefore, convective solvent flow may be involved in enhancing skin transport by microneedles, this possibility remains unconfirmed.

The objectives of the present study are: (1) to evaluate the penetration of fluorescent dye into skin after application of microneedles using confocal laser scanning microscopy, (2) to evaluate the effect of pretreatment of puncture by microneedles with 150 μm length on *in*-*vitro* skin permeation of hydrophilic peptides of varying molecular weight and (3) to explain the penetration-enhancing effect caused by microneedles based on the relationship between D~2~O flux and solute transport clearance.

2. Materials and methods {#s0010}
========================

2.1. Chemicals and reagents {#s0015}
---------------------------

Tetrapeptide-3, hexapeptide, acetyl hexapeptide-3 and oxytocin were all purchased from ChuanKangPaiDe Biological Technology (Sichuan, China). HPLC-grade acetonitrile was obtained from Dikma Technology (Beijing, China). All solutions were prepared with ultrapure water (resistivity\>18 MΩ cm).

2.2. Skin preparation {#s0020}
---------------------

Porcine ear skins (from adult pig) were purchased from a local slaughterhouse immediately following death, and the dermatomed skins with a thickness of 800 μm were carefully obtained with a skin grafting knife.

2.3. Microneedle arrays {#s0025}
-----------------------

Microneedle arrays and applicator were developed by our group and made by Nasheng Microelectronics (Suzhou) Co. Ltd., China. Arrays of solid microneedle ([Fig. 1](#f0005){ref-type="fig"}A) were fabricated by dry and wet etching from silicon wafers. Each microneedle array has 121 needles of 150 μm-length in an area of 4 mm×4 mm. The array was fixed onto a supporting column (5 mm in diameter) of applicator ([Fig. 1](#f0005){ref-type="fig"}B), which provided insertion force of nearly 2 N. Microneedle arrays were inserted into the skin with a constant vibration frequency for 20 s.

2.4. In vitro skin permeation studies {#s0030}
-------------------------------------

The experiments were performed with a system employing Franz vertical diffusion cells. After pretreatment by microneedles for 20 s, the skin samples were clamped in vertical Franz diffusion cells (2.5 mL) with the stratum corneum side facing the donor compartment, giving an effective permeation area of 0.66 cm^2^. The receptor and donor compartments were filled with phosphate buffer (pH 7.4). After equilibrium for 1 h, the receptor compartment was filled with PBS. The donor compartments were replaced with 300 μL peptides dissolved in PBS prepared with either H~2~O or D~2~O. Diffusion cells were stirred by a magnetic bar at 280 rpm at 37 °C. The samples of receptor cell were sampled at predetermined time intervals and the receptor phase was immediately refreshed by equal volume of PBS buffer to keep a constant volume. The samples were centrifuged (4000×g for 7 min), and the supernatant analyzed by HPLC/UV. Results are expressed as the mean±S.D. (*n*=3--4 independent samples). The osmotic concentration differential was adjusted to 3.08, 0, --3.08 mol/L by adding NaCl to donor or receiver compartments[@bib15].

2.5. Microneedle insertion imaging {#s0035}
----------------------------------

Confocal laser scanning microscopy (CLSM) was used to observe the microconduits created by microneedle. Skin was pierced by microneedles coated with calcein hydrogel, and removed immediately and placed upon a glass slide. The stratum comeum side at 20 μm was scanned at high speed through the *Z* axis (*Z*, defined as perpendicular distance to the skin surface from the dermis) of a ZEISS PASCAL inverted confocal laser scanning microscope (LSM 510 with an attached Zeiss Axiovert 200 M microscope).

2.6. Quantitation of the peptides {#s0040}
---------------------------------

The quantitative determination of tetrapeptide-3, hexapeptide, acetyl hexapeptide-3 and oxytocin were conducted by LC-2010 A HPLC/UV (Shimadzu, Japan). The experiments were carried out under gradient elution mode using a mobile phase consisting of 0.1% (*v/v*) trifluoroacetic acid aqueous solution and 0.1% (*v/v*) trifluoroacetic acid acetonitrile solution at a flow rate of 1 mL/min. The analysis was performed on a YMC-Pack ODS-A C18 column (250 mm×4.6 mm i.d., 5 μm, YMC Inc., USA). The injection volume was 20 μL. The column eluant was monitored at 220 nm. D~2~O were analyzed by measuring the intensity of the O-D stretching vibrational band at 2512 cm^−1^ in infrared spectroscopic spectra (Shimadzu, Japan).

2.7. Data analysis {#s0045}
------------------

The accumulative amount (μmol/cm^2^) of drug permeating across a unit diffusion surface into the receptor compartment was calculated and plotted as a function of time. Steady-state skin permeation rates were determined by linear regression analysis of the amount of peptides penetrated against time. The permeation clearance (CL, μL/h) was calculated using the following equation: CL=(d*C*~R~/d*t*)*V*~R~/*C*~D~, where *C*~R~ and *C*~D~ are the drug concentration in the receiver and donor solution, respectively, *V*~R~ is the volume of the receiver solution, and *t* is time.

3. Results {#s0050}
==========

3.1. Fluorescence microscopic observations {#s0055}
------------------------------------------

In order to directly verify the formation of microconduits in the skin, microneedles with 150 μm length were used with an insertion system designed to pierce the skin at a constant speed. [Fig. 2](#f0010){ref-type="fig"} shows the distribution of calcien fluorescence at skin depths of 0, 20, 40, 60, 80 and 100 μm after microneedle pretreatment. Confocal images confirmed the formation of microconduits by microneedle pretreatment. Calcein fluorescence was confined to microconduits, while dots correspond to sites of microconduits from the array. Calcein could diffuse into deeper skin layers. At *Z*=80 μm, the fluorescence of calcein around microconduits are still visible, but at *Z*=100 μm, there is trace amount of calcein fluorescence and microconduits is disappeared.

3.2. Permeation studies with hydrophilic peptides varying in molecular weight {#s0060}
-----------------------------------------------------------------------------

To assess whether microneedle pretreatment resulted in an increased skin transport of hydrophilic peptides, the permeabilities of acetyl hexapeptide-3 through untreated and microneedle-treated porcine ear skin were compared. Experiments were conducted under mode of microneedle application (auto) and the acetyl hexapeptide-3 solution (90 mmol/L). [Fig. 3](#f0015){ref-type="fig"} shows the cumulative amount permeated through porcine ear skin during 24 h. The passive flux of acetyl hexapeptide-3 across untreated skin was 0.014±0.002 μmoL/cm·h. After microneedle treatment, the flux increased to 0.44±0.12 μmoL/cm·h, an enhancement of more than 31-fold.

Four peptides (tetrapeptide-3, hexapeptide, acetyl hexapeptide-3 and oxytocin, 0.09 mol/L) were used to study the relationship between permeability rate and molecular weight with and without microneedle pretreatment. All of the peptides have been widely used in medical and cosmetic industries. [Table 1](#t0005){ref-type="table"} summarizes the *in vitro* cumulative delivery of peptides across porcine ear skin over 24 h. Microneedle pretreatment significantly enhanced the penetration of all peptides.

[Fig. 4](#f0020){ref-type="fig"} shows the cumulative amount of these peptides after application of the microneedles during 24 h. Besides the dipeptides studied here, transport for [l]{.smallcaps}-carnitine (161.2 Da) was also studied. The permeation rates of [l]{.smallcaps}-carnitine, tetrapeptide-3, hexapeptide, acetyl hexapeptide-3 and oxytocin were 1.95±0.21, 0.90±0.09, 0.84±0.11, 0.42±0.14, 0.16±0.05 μmoL/cm·h, respectively. [Fig. 5](#f0025){ref-type="fig"} shows an inverse relationship between permeability and molecular weight of the peptides.

3.3. Effect of microneedles on the permeability of D~2~O and hydrophilic drugs {#s0065}
------------------------------------------------------------------------------

The enhancing effects of ultrasound and iontophoresis on skin permeation of hydrophilic compound can be explained by inducing convective solvent flow[@bib13]. In the present study, we analyzed how the transport of the hydrophilic compound acetyl hexapeptide-3 was improved by microneedles based on the relationship between hydrophilic solute and vehicle (D~2~O) transport. To assess the skin permeability of D~2~O and acetyl hexapeptide-3, the time course of D~2~O flux and permeation clearance of acetyl hexapeptide-3 under various osmotic concentrations were determined ([Fig. 6](#f0030){ref-type="fig"}). A good correlation was observed between the acetyl hexapeptide-3 clearance and the D~2~O flux (*r*=0.96, slope of the regression line: 0.23±0.037). The results suggest that convection generated by microneedles plays an important role in skin permeability of hydrophilic drugs.

4. Discussion {#s0070}
=============

The present results found that pretreatment with solid microneedles with a length of 150 μm create visible microconduits in a "poke and patch" approach. The presence of microconduits created by microneedles was in accordance with our intended purpose, *i.e*. to puncture the epidermis without reaching nerves in the dermis. In the "poke and patch" approach, it is very important for the microconduits to remain open at least 72 h under occlusive conditions[@bib16]. Many microneedle-base studies have shown that the permeability for different compounds is increased up to four orders in magnitude[@bib17; @bib18]. As observed from [Fig. 4](#f0020){ref-type="fig"}, transdermal permeation of all peptide was sustained for 24 h after treatment of microneedles. Therefore, solid microneedles could be conveniently incorporated into a transdermal patch to prolong peptide release.

Among various therapeutic peptide-delivery techniques, microneedle-assisted peptide delivery is currently believed to be the most efficient method. Most published studies have focused on the high molecular weight compounds, such as protein, vaccine and insulin[@bib19; @bib20; @bib21; @bib22; @bib23]. Hitherto, there are few studies examining whether microneedles could deliver peptides with various molecular weights, especially those with low molecular weight. Even less is known about the permeation mechanisms for these compounds. In the present study, *in vitro* results on the permeation of peptides with different molecular weights indicate that microneedles can remarkably enhance the transdermal delivery of all hydrophilic peptides. The skin permeation of peptides depends on their molecular weight and decreases as the molecular weight increases. In addition, the enhanced skin permeation of peptides produced by microneedle pretreatment may be caused by the generation of convection. This study demonstrates that microneedles provide an attractive route to deliver low molecular weight peptides to the skin. The transdermal administration of such compounds is of significant current interest in clinical medicine and the cosmetic industry.
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![The microneedle array and the autoapplicator employed in this study. (A) Microneedle array; (B) autoapplicator.](gr1){#f0005}

![Calcein fluorescence across the porcine ear skin at *Z*=0, 20, 40, 60, 80 and 100 μm following microneedle pretreatment. *Z* direction is defined as perpendicular distance to the skin surface from the dermis. Fluorescence-emission signal of calcein is represented by green color.](gr2){#f0010}

![The permeation profiles of acetyl hexapeptide-3 across porcine ear skin with and without pretreatment by microneedles.](gr3){#f0015}

![*In vitro* transdermal permeation of a series of peptides in solution across porcine ear skin 24 h after pretreatment by microneedles.](gr4){#f0020}

![Relationship between the permeation rate of five model peptides and their corresponding molecular weight.](gr5){#f0025}

![Relationship between D~2~O flux and permeation clearance of acetyl hexapeptide-3.](gr6){#f0030}

###### 

Transdermal accumulation of peptides with and without microneedle pretreatment.

  Peptides               Cumulative amount (μmol/cm^2^)                
  ---------------------- -------------------------------- ------------ -------
  Oxytocin               6.69±0.57                        0.12±0.008   55.75
  Acetyl hexapeptide-3   11.11±3.1                        0.29±0.073   38.31
  Hexapeptide            17.76±2.38                       0.49±0.12    36.24
  Tetrapeptide-3         18.96±5.19                       0.58±0.16    32.69
